Virax Biolabs Group (VRAX) Debt to Equity (2020 - 2025)
Virax Biolabs Group (VRAX) debt to equity from Mar 31, 2020 to Sep 30, 2025. The current Virax Biolabs Group (VRAX) debt to equity is 10.17%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Virax Biolabs Group (VRAX)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 6.67% | +62.73% |
| 2024 | 4.10% | +149.36% |
| 2023 | 1.64% | N/A |
| 2022 | 0.00% | -100.00% |
| 2021 | -30.00% | -58.16% |
| 2020 | -71.70% | N/A |
Comparison Virax Biolabs Group (VRAX) debt to equity with competitors
Virax Biolabs Group (VRAX) debt to equity is 10.17%.